These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7389018)

  • 21. The intraocular penetration of chloramphenicol succinate in rabbits.
    Broughton W; Goldman JN
    Ann Ophthalmol; 1973 Jan; 5(1):71-4 passim. PubMed ID: 4683788
    [No Abstract]   [Full Text] [Related]  

  • 22. [Levomycetin dispersity and its effect on the intensity of absorption].
    Batuashvili TA
    Antibiotiki; 1980 Aug; 25(8):585-9. PubMed ID: 7406470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
    Kauffman RE; Thirumoorthi MC; Buckley JA; Aravind MK; Dajani AS
    J Pediatr; 1981 Dec; 99(6):963-7. PubMed ID: 7310593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ampicillin, erythromycin and chloramphenicol penetration into rabbit aqueous humor.
    Goldman JN; Broughton W; Javed H; Lauderdale V
    Ann Ophthalmol; 1973 Feb; 5(2):147-56. PubMed ID: 4701066
    [No Abstract]   [Full Text] [Related]  

  • 25. The particle size evaluation of parenteral suspensions of chloramphenicol and correlation of particle size to plasma levels.
    Kitamori N; Kawajiri S; Matsuzawa T
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2597-602. PubMed ID: 1017098
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bioavailability of chloramphenicol palmitate suspension].
    Morasso MI; Hirmas E; Firmani E; Pezoa R; Cid E
    Pharm Acta Helv; 1980; 55(10):270-3. PubMed ID: 7454734
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of intestinal absorption of chloramphenicol.
    Chakrabarti K; Banerjee S
    Indian J Exp Biol; 1977 Apr; 15(4):302-3. PubMed ID: 914339
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pseudomorphism of chloramphenicol stearate and palmitate in relationship availability].
    Cameroni R; Coppi G; Forni F; Gamberini G; Ferioli V
    Farmaco Prat; 1983 Apr; 38(4):173-82. PubMed ID: 6861978
    [No Abstract]   [Full Text] [Related]  

  • 29. [Suspensions of chloramphenicol palmitate. Enzymatic hydrolysis and resorption].
    Dony J; De Roeck A
    J Pharm Belg; 1965; 20(11):475-83. PubMed ID: 5864900
    [No Abstract]   [Full Text] [Related]  

  • 30. An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.
    Glazko AJ; Kinkel AW; Alegnani WC; Holmes EL
    Clin Pharmacol Ther; 1968; 9(4):472-83. PubMed ID: 5655479
    [No Abstract]   [Full Text] [Related]  

  • 31. Dissolution of slightly soluble drugs. V. Effect of particle size on gastrointestinal drug absorption and its relation to solubility.
    Kaneniwa N; Watari N; Iijima H
    Chem Pharm Bull (Tokyo); 1978 Sep; 26(9):2603-14. PubMed ID: 699204
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of chloramphenicol palmitate in neonates.
    Shankaran S; Kauffman RE
    J Pediatr; 1984 Jul; 105(1):113-6. PubMed ID: 6737126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of thyroid hormone on the absorption of L-proline, chloramphenicol and digitoxin].
    Ahmadiar N; Ruiz-Torres A
    Arzneimittelforschung; 1979; 29(2):284-6. PubMed ID: 582140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Bioavailability and therapeutic efficacy.
    Withey RJ
    Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacokinetic evaluation of 2 oral forms of chloramphenicol in children with typhoid].
    Bravo ME; Horwitz I; Sánchez A; Arancibia A
    Rev Chil Pediatr; 1986; 57(2):121-5. PubMed ID: 3550926
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.
    Aguiar AJ; Krc J; Kinkel AW; Samyn JC
    J Pharm Sci; 1967 Jul; 56(7):847-53. PubMed ID: 6034828
    [No Abstract]   [Full Text] [Related]  

  • 37. Special characteristics of absorption and excretion of chloramphenicol in premature and newborn infants.
    Nishimura T; Kotani Y
    Bull Osaka Med Sch; 1970 Oct; 16(2):169-81. PubMed ID: 5511545
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissolution of slightly soluble drugs. IV. Effect of particle size of sulfonamides on in vitro dissolution rate and in vivo absorption rate, and their relation to solubility.
    Kaneniwa N; Watari N
    Chem Pharm Bull (Tokyo); 1978 Mar; 26(3):813-26. PubMed ID: 647854
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum levels of chloramphenicol during simultaneous administration of penicillin in children].
    Windorfer A
    Z Kinderheilkd; 1972; 112(1):79-88. PubMed ID: 5019027
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioavailability and tissue elimination of chloramphenicol following parenteral administration in the preruminant calf.
    Archimbault P; Ambroggi G; Joineaud J
    Ann Rech Vet; 1987; 18(1):85-90. PubMed ID: 3579187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.